Vimarsana
Biggest News Aggregation in the World

Abbott Navitor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abbott Navitor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abbott Navitor Today - Breaking & Trending Today

3 No-Brainer Medical Device Stocks to Buy Right Now - Vimarsana News

3 No-Brainer Medical Device Stocks to Buy Right Now

These companies have consistently delivered revenue and EPS gains.

Source: fool.com
Data backs Abbott Navitor, Amulet heart implants - Vimarsana News

Data backs Abbott Navitor, Amulet heart implants

Abbott (NYSE:ABT) announced today that studies support its next-generation Navitor TAVI system and its Amplatzer Amulet device.

Abbott Receives FDA Approval for Navitor TAVI System - Vimarsana News

Abbott Receives FDA Approval for Navitor TAVI System

Abbott's new Navitor device features advancements to improve patient care, including reducing or eliminating risk of blood leakage around valve implant

Abbott wins FDA nod for Navitor transcatheter aortic valve implant - Vimarsana News

Abbott wins FDA nod for Navitor transcatheter aortic valve implant

Abbott (NYSE:ABT) announced today that it received FDA approval for its latest-generation transcatheter aortic valve implant (TAVI) system.

Abbott nabs European approval for Navitor aortic heart valve replacement - Vimarsana News

Abbott nabs European approval for Navitor aortic heart valve replacement

May 17, 2021 11:35am The Navitor artificial heart valve is implanted using Abbott’s CE-marked FlexNav delivery device and reduces the blood leaks that often occur after replacement. (Abbott) After Boston Scientific retired its entire line of Lotus Edge replacement heart valves late last year amid a flurry of issues with its delivery system, Abbott has stepped up to fill in the gap in the transcatheter aortic valve replacement market. Abbott’s Navitor TAVR system has received a CE mark, making it available in Europe to those with severe aortic stenosis and a high or extreme risk of...